|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2023
As of Feb 28, 2023
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Nov 30, 2022
|
Q3 FY2022
As of Aug 31, 2022
|
Q2 FY2022
As of May 31, 2022
|
Q1 FY2022
As of Feb 28, 2022
|
Q4 FY2021
As of Nov 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Operating digital assets | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expense | ||||||||||||||||||||
| Overpayment to related parties | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Right-of-use asset | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Note payable - related party | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||||||
| Series A Convertible Preferred Stock, 1,000,000 designated, 140,000 shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock: $0.0001 par value, 250,000,000 shares authorized; 11,752,329 and 10,979,058 shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated earnings (deficit) | ||||||||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity (Deficit) | ||||||||||||||||||||
Loading...
